NO913816L - Fremstilling av liposom- og lipidkompleksblandinger. - Google Patents

Fremstilling av liposom- og lipidkompleksblandinger.

Info

Publication number
NO913816L
NO913816L NO91913816A NO913816A NO913816L NO 913816 L NO913816 L NO 913816L NO 91913816 A NO91913816 A NO 91913816A NO 913816 A NO913816 A NO 913816A NO 913816 L NO913816 L NO 913816L
Authority
NO
Norway
Prior art keywords
compounds
liposome
aprotic solvent
liposom
preparation
Prior art date
Application number
NO91913816A
Other languages
English (en)
Other versions
NO913816D0 (no
NO303205B1 (no
Inventor
Jr Francis C Szoka
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO913816D0 publication Critical patent/NO913816D0/no
Publication of NO913816L publication Critical patent/NO913816L/no
Publication of NO303205B1 publication Critical patent/NO303205B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
NO913816A 1989-03-31 1991-09-27 FremgangsmÕte for fremstilling av lipidkompleksoppslemming NO303205B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05
PCT/US1990/001646 WO1990011780A1 (en) 1989-03-31 1990-03-28 Preparation of liposome and lipid complex compositions

Publications (3)

Publication Number Publication Date
NO913816D0 NO913816D0 (no) 1991-09-27
NO913816L true NO913816L (no) 1991-11-26
NO303205B1 NO303205B1 (no) 1998-06-15

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913816A NO303205B1 (no) 1989-03-31 1991-09-27 FremgangsmÕte for fremstilling av lipidkompleksoppslemming

Country Status (12)

Country Link
EP (1) EP0467954B1 (no)
JP (1) JP2798302B2 (no)
AT (1) ATE137403T1 (no)
AU (1) AU638245B2 (no)
CA (1) CA2050679C (no)
DE (1) DE69026820T2 (no)
DK (1) DK0467954T3 (no)
ES (1) ES2087151T3 (no)
HK (1) HK1000912A1 (no)
HU (1) HU208070B (no)
NO (1) NO303205B1 (no)
WO (1) WO1990011780A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
PT707472E (pt) 1993-07-08 2001-07-31 Liposome Co Inc Processo para controlar a dimensao de lipossomas
AU678609B2 (en) * 1993-09-29 1997-06-05 Gist-Brocades N.V. A novel antifungal composition
CA2223179A1 (en) * 1995-06-07 1996-12-19 Bob Dale Brown Phosphonic acid-based cationic lipids
WO2000037050A1 (en) * 1998-12-22 2000-06-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-insoluble drug delivery system
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
DE60134265D1 (de) * 2000-12-01 2008-07-10 Biomira Inc Herstellung grosser liposome durch infusion in peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
EP2146692A1 (en) * 2007-03-19 2010-01-27 Fresenius Kabi Oncology Limited Proliposomal and liposomal compositions
CA2705797A1 (en) * 2007-11-14 2009-05-22 The Regents Of The University Of California Sterol-modified amphiphilic lipids
ES2834006T3 (es) * 2008-09-27 2021-06-16 Jina Pharmaceuticals Inc Preparados farmacéuticos a base de lípidos para aplicación tópica
KR101801426B1 (ko) 2010-07-14 2017-12-20 인스티투트 오브 마타리아 메디카, 차이니즈 아카데미 오브 메디칼 사이언스 인슐린-지질 복합물 및 그의 제조방법과 그의 제제
WO2016022549A1 (en) 2014-08-04 2016-02-11 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into lipid vesicles
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関　則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
NO913816D0 (no) 1991-09-27
DE69026820D1 (de) 1996-06-05
DK0467954T3 (da) 1996-05-28
HUT59818A (en) 1992-07-28
HK1000912A1 (en) 1998-05-08
AU5434590A (en) 1990-11-05
ES2087151T3 (es) 1996-07-16
AU638245B2 (en) 1993-06-24
ATE137403T1 (de) 1996-05-15
CA2050679C (en) 1998-09-22
JP2798302B2 (ja) 1998-09-17
NO303205B1 (no) 1998-06-15
JPH04506207A (ja) 1992-10-29
EP0467954A4 (en) 1992-06-03
CA2050679A1 (en) 1990-10-01
HU903559D0 (en) 1991-12-30
WO1990011780A1 (en) 1990-10-18
EP0467954B1 (en) 1996-05-01
EP0467954A1 (en) 1992-01-29
DE69026820T2 (de) 1996-11-28
HU208070B (en) 1993-08-30

Similar Documents

Publication Publication Date Title
NO913816D0 (no) Fremstilling av liposom- og lipidkompleksblandinger.
DE3867866D1 (de) Liposomzubereitung und ihre herstellung.
CA1262093C (en) STEROID LIPOSOMES
DE3482161D1 (de) Zubereitung von arzneimittelhaltigen lipidvesikeln und verfahren zu deren herstellung.
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
ES2074878T3 (es) Polvo preliposomal de polieno liposomal y metodo para su preparacion.
GR3020068T3 (en) Preparation of lipidic microparticles
IE780464L (en) Liposome compositions
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
EP1419789A3 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
DE68904999T3 (de) Verfahren zur Herstellung dispergierbarer kolloidaler Systeme aus amphiphilen Lipiden in Form von Liposomen in Submikrongrösse.
ZA884513B (en) Drug emulsion
DE69738416T2 (de) Liposomale zubereitungen von indolocarbazol-derivaten
FI103178B (fi) Menetelmä vaikuttavaa ainetta sisältävien vesipohjaisten liposomisuspe nsioiden valmistamiseksi
JPS5675438A (en) Method for stabilizing aqueous solution of cyanocobalamin
DE3851842D1 (de) Wässrige bereitung von liposomenzusammensetzungen.